Related Experiment Video
Updated: Jul 17, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
Hepatitis E virus in pregnancy - vaccine and HEV reinforced with polymer
Kamila Gorczyca1, Maciej Paszkowski2
1GYNECOLOGY, CHAIR AND DEPARTMENT OF OBSTETRICS AND PERINATOLOGY, MEDICAL UNIVERSITY OF LUBLIN, LUBLIN, POLAND.
Abstract:
The hepatitis E virus (HEV) causes self-limiting viral hepatitis. It is now global, both in developing and low-industrialized countries. With infection, the predominance of infections is asymptomatic but can cause death. Pregnant women are particularly vulnerable to severe complications. This article summarizes the current knowledge about HEV infection during pregnancy, focusing on immunology, transmission, complications in both pregnant and newborn women, and polymer-boosted vaccines. The development of a polymer-reinforced vaccine may in the future solve the problem of the HEV virus, which is particularly dangerous for pregnant women.
Related Concept Videos
Teratogenicity
Vaccine Production
Poliomyelitis
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Virion Maturation and Assembly

